5Y News | Portfolio Company PAM2L Biotechnologies Closes Pre-A Round of Over 100 Million RMB
Leveraging synthetic biology and machine learning as dual engines to drive bio-based materials and product development.
Articles
"Bioyen Bio" Closes Over 100 Million Yuan Pre-A Round, Led by Yunqi Capital | Yunqi Capital
Leading research in materials synthetic biology, building an efficient innovation R&D platform
Multiple Yunqi Capital Portfolio Companies Recognized as "China Industrial Digitalization Leaders" with Nine Honors | Yunqi Capital News
Innovation Never Stops — Co-Creating the Future of Technology
"Bitling Technology" Selected for 2022 *China Digital Security Capability Atlas (Select Edition)* | Yunqi Tech π
Building a Secure Software Development Foundation
Yunqi Capital Ranked Qimingpian 2022 "Top 4 Best Early-Stage Firm" and Other Annual Awards | Yunqi Capital Bulletin
Building momentum, staying true to the original mission.
Allen Luo and Zheng Gang: Let the Law Be the Law, and Let Emotions Be Emotions
A story about a VC-founder relationship hitting rock bottom.
World Record Shattered! "RenShuo Solar Energy" Achieves 29.0% Efficiency with Perovskite Tandem Cells | Yunqi Tech π
Breaking Through on Tech R&D: Perovskite Cell Efficiency Hits Another Record
Yunqi Capital Named to CVCRI 2022 "China's Most Influential Early-Stage Investment Firms" and Other Annual Awards | Yunqi Capital News
Tech Innovation, Our Shared Future
The Dawning New Cycle | 5Y Annual Share
Where our confidence lies.
Yinjia Biotech Closes Nearly RMB 100 Million Series A Round to Accelerate Buildout of Upstream Core Protein Ingredient Synthetic Biology Platform
Staying true to our mission as "protein craftsmen."